In vitro and in vivo evaluation of microparticulate drug delivery systems composed of macromolecular prodrugs

被引:14
|
作者
Onishi, Hiraku [1 ]
Machida, Yoshiharu [1 ]
机构
[1] Hoshi Univ, Dept Drug Delivery Res, Shinagawa Ku, Tokyo 1428501, Japan
关键词
macromolecular prodrug; microparticles; nanoparticles; controlled release; in vivo behavior;
D O I
10.3390/molecules13092136
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Macromolecular prodrugs are very useful systems for achieving controlled drug release and drug targeting. In particular, various macromolecule-antitumor drug conjugates enhance the effectiveness and improve the toxic side effects. Also, polymeric micro- and nanoparticles have been actively examined and their in vivo behaviors elucidated, and it has been realized that their particle characteristics are very useful to control drug behavior. Recently, researches based on the combination of the concepts of macromolecular prodrugs and micro- or nanoparticles have been reported, although they are limited. Macromolecular prodrugs enable drugs to be released at a certain controlled release rate based on the features of the macromolecule-drug linkage. Micro- and nanoparticles can control in vivo behavior based on their size, surface charge and surface structure. These merits are expected for systems produced by the combination of each concept. In this review, several micro- or nanoparticles composed of macromolecule-drug conjugates are described for their preparation, in vitro properties and/or in vivo behavior.
引用
收藏
页码:2136 / 2155
页数:20
相关论文
共 50 条
  • [21] In vitro and in vivo evaluation of a melamine dendrimer as a vehicle for drug delivery
    Neerman, MF
    Zhang, W
    Parrish, AR
    Simanek, EE
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2004, 281 (1-2) : 129 - 132
  • [22] In vitro and in vivo adhesion testing of mucoadhesive drug delivery systems
    Chary, RBR
    Vani, G
    Rao, YM
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1999, 25 (05) : 685 - 690
  • [23] The in vitro and in vivo evaluation of new synthesized prodrugs of 5-OH-DPAT for iontophoretic delivery
    Ackaert, O. W.
    De Graan, J.
    Capancioni, R.
    Della Pasqua, O. E.
    Dijkstra, D.
    Westerink, B. H.
    Danhof, M.
    Bouwstra, J. A.
    JOURNAL OF CONTROLLED RELEASE, 2010, 144 (03) : 296 - 305
  • [24] Nasal delivery of antisense oligonucleotides: in vitro evaluation of a thiomer/glutathione microparticulate delivery system
    Vetter, A.
    Bernkop-Schnuerch, A.
    JOURNAL OF DRUG TARGETING, 2010, 18 (04) : 303 - 312
  • [25] Development of drug delivery systems for macromolecular drugs
    Takakura, Y
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 1996, 116 (07): : 519 - 532
  • [26] Evolution of macromolecular complexity in drug delivery systems
    Kakkar, Ashok
    Traverso, Giovanni
    Farokhzad, Omid C.
    Weissleder, Ralph
    Langer, Robert
    NATURE REVIEWS CHEMISTRY, 2017, 1 (08)
  • [27] MACROMOLECULAR AND MAGNETIC CONTROLLED DRUG DELIVERY SYSTEMS
    LANGER, R
    IEEE TRANSACTIONS ON BIOMEDICAL ENGINEERING, 1983, 30 (08) : 524 - 524
  • [28] Evolution of macromolecular complexity in drug delivery systems
    Ashok Kakkar
    Giovanni Traverso
    Omid C. Farokhzad
    Ralph Weissleder
    Robert Langer
    Nature Reviews Chemistry, 1
  • [29] Thiomers:: development and in vitro evaluation of a peroral microparticulate peptide delivery system
    Krauland, AH
    Bernkop-Schnürch, A
    EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2004, 57 (02) : 181 - 187
  • [30] Drug delivery systems: Anticancer prodrugs and their polymeric conjugates
    Greenwald, RB
    EXPERT OPINION ON THERAPEUTIC PATENTS, 1997, 7 (06) : 601 - 609